These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 187207)

  • 1. Stimulation of anti-tumour immunity in guinea-pigs by methanol extraction residue of BCG.
    Wainberg MA; Deutsch V; Weiss DW
    Br J Cancer; 1976 Nov; 34(5):500-8. PubMed ID: 187207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1973 Dec; 51(6):1897-908. PubMed ID: 4358147
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction--heterogeneity of the cellular immune response.
    Dvorak HF
    Adv Exp Med Biol; 1979; 114():369-74. PubMed ID: 223416
    [No Abstract]   [Full Text] [Related]  

  • 4. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG).
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
    Fidler IJ; Kataoka T; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against guinea pig hepatomas by pretreatment with subcelluar fractions of Mycobacterium bovis (BCG).
    Minden P; Wainberg M; Weiss DW
    J Natl Cancer Inst; 1974 May; 52(5):1643-5. PubMed ID: 4364739
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of tumor growth after intradermal injection of BCG extracts: a comparison of results in strain-2 guinea pigs from the National Institutes of Health and from the National Jewish Hospital and Research Center.
    Zbar B; Minden P; McClatchy JK; Rapp HJ
    J Natl Cancer Inst; 1976 Feb; 56(2):443-4. PubMed ID: 176390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
    [No Abstract]   [Full Text] [Related]  

  • 9. Methanol extraction residue of BCG in the treatment of transplanted rat tumours.
    Hopper DG; Pimm MV; Baldwin RW
    Br J Cancer; 1975 Feb; 31(2):176-81. PubMed ID: 169861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vertical transmission of tumour resistance in guinea pigs.
    Wainberg MA; Minden P; Weiss DW
    Nature; 1976 Jan; 259(5540):213-5. PubMed ID: 175279
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression and regression of a transplanted tumor in the guinea pig colon mediated by Mycobacterium bovis, strain BCG.
    Harmel RP; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1975 Feb; 54(2):515-7. PubMed ID: 234537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief communication: antigenic relationship between Mycobacterium bovis (BCG) and a guinea pig hepatoma.
    Borsos T; Rapp HJ
    J Natl Cancer Inst; 1973 Sep; 51(3):1085-6. PubMed ID: 4355214
    [No Abstract]   [Full Text] [Related]  

  • 13. Responses of tumors induced in inbred guinea pig strain JY=1 and strain Hartley/F to BCG.
    Kataoka T; Tokunaga T; Murohashi T
    J Natl Cancer Inst; 1977 Mar; 58(3):803-8. PubMed ID: 320348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple in vitro mechanisms of tumor cytotoxicity demonstrated in the line-1 guinea pig hepatoma model.
    Osteen RT; Piessens WF; David JR; Churchill WH
    J Natl Cancer Inst; 1975 Oct; 55(4):873-8. PubMed ID: 52720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-specific, cell-mediated immunity in guinea pigs with tumors.
    Littman BH; Meltzer MS; Cleveland RP; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1973 Nov; 51(5):1627-35. PubMed ID: 4762937
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor immunity produced by the intradermal inoculation of living tumor cells and living Mycobacterium bovis (strain BCG).
    Zbar B; Bernstein I; Tanaka T; Rapp HJ
    Science; 1970 Dec; 170(3963):1217-8. PubMed ID: 4920656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin.
    Zbar B; Bernstein ID; Rapp HJ
    J Natl Cancer Inst; 1971 Apr; 46(4):831-9. PubMed ID: 4324814
    [No Abstract]   [Full Text] [Related]  

  • 18. An experimental model for immunotherapy of cancer.
    Zbar B; Ribi E; Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():3-9. PubMed ID: 4595326
    [No Abstract]   [Full Text] [Related]  

  • 19. Antitumor activity of bacterial infection. II. effect of Listeria monocytogenes on growth of a guinea pig hepatoma.
    Bast RC; Zbar B; Miller TE; Mackaness GB; Rapp HJ
    J Natl Cancer Inst; 1975 Mar; 54(3):757-61. PubMed ID: 164568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.
    Minden P; McClatchy JK; Wainberg M; Weiss DW
    J Natl Cancer Inst; 1974 Nov; 53(5):1325-31. PubMed ID: 4139280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.